Vitamin D3 for Life

Live Enlightened

Article

Free, Albumin-Bound and Total Vitamin D in the Blood: Study Summary

Previous related pageFree, Albumin-Bound and Total Vitamin D in the Blood: Full StudyNext related pageFrom cellular uptake to activation and clearance: the vitamin D metabolism pathway
Study at a glance

What are free, albumin-bound and total vitamin D?

This page compares ways that 25-hydroxyvitamin D is carried in the blood. Most is attached to vitamin D-binding protein. A smaller amount is attached to another protein called albumin. A tiny amount is unattached, or free. A total measurement includes all three amounts.

Who was studied to compare free and total vitamin D?

The evidence includes tests on human blood and studies of people with liver disease. It also includes 472 people in a vitamin D supplement study. Two rare cases involved people who could not make the usual vitamin D-binding protein.

When did free and total vitamin D measurements differ?

In liver disease, total levels could be lower while the amount of free 25-hydroxyvitamin D remained relatively unchanged. Common inherited differences in the carrier protein affected total measurements more clearly than directly measured free amounts. The two rare cases had extremely low total levels without equally severe disruption of calcium control or bone health. These unusual cases do not show that ordinary low vitamin D levels are harmless.

Do these studies show that only free vitamin D matters?

The amount of carrier protein affects what a total blood measurement represents. Free vitamin D measurements do not tell us how vitamin D acts in every tissue. These studies do not establish that only free vitamin D matters. They also do not define a free vitamin D blood level that everyone should aim for.

Read the full article below ↓

Circulating 25-hydroxyvitamin D exists mainly bound to vitamin D-binding protein, with a smaller albumin-bound pool and a tiny free fraction. These compartments are related by binding equilibrium, but they are not physiologically identical. This Study Summary gives the faster route through the evidence; the deeper methods, results and inference boundaries are in Free, Albumin-Bound and Total Vitamin D in the Blood: Full Study.

What is the central physiological distinction?

Total 25(OH)D includes DBP-bound, albumin-bound and free 25(OH)D. Under ordinary conditions DBP carries most of the circulating metabolite because its binding affinity is much higher than albumin’s. Albumin contributes weaker binding, while the free pool is extremely small.

Classic direct binding work estimated about 88% of 25(OH)D as DBP-bound and about 0.03% as free in normal serum, with most of the remainder associated with albumin. Those percentages vary with physiology and method, so they are best understood as an illustration of the normal hierarchy rather than universal constants.

Why does the carrier matter?

DBP helps determine the size of the total circulating reservoir. In liver disease, where DBP and albumin can be reduced, total 25(OH)D may fall while absolute free 25(OH)D is relatively preserved. Vitamin D Binding Protein Explained gives the wider carrier biology.

Common DBP phenotypes also influence total and free measures, although much less dramatically than complete loss of the protein. In a 472-person supplementation study, phenotype-related differences were more evident for total 25(OH)D and DBP than for directly measured free 25(OH)D.

What do rare GC mutations show?

Rare human loss of DBP provides a strong causal test. A 2019 patient with homozygous deletion of GC had a total 25(OH)D concentration of about 0.079 ng/mL, but directly measured free 25(OH)D was 1.8 pg/mL and calcium/PTH regulation was comparatively preserved. A later unrelated patient with a pathogenic GC variant likewise had extremely low total vitamin D metabolites without obligatory severe metabolic bone disease.

These cases show that total concentration is strongly carrier-dependent. They do not show that ordinary low total 25(OH)D is harmless. Complete DBP loss is an exceptional genetic state and cannot be treated as a model of routine deficiency.

Does free mean biologically active?

Not in a universal sense. Free 25(OH)D is unbound and therefore physically distinct, but circulating free concentration is not the same thing as tissue action. The selected studies do not map uptake and response across every tissue, so they cannot establish that DBP-bound material is biologically irrelevant everywhere. Intracellular activation and receptor signalling also occur downstream of the blood measurement.

Likewise, weaker albumin binding does not prove that the entire albumin-bound pool is uniformly available to every tissue. Vitamin D Transport Proteins explains why transport and tissue delivery cannot be reduced to one percentage.

How was this evidence generated?

The evidence comes from several different human designs rather than one repeated type of study. The foundational work directly measured the free fraction in serum and experimentally removed DBP to identify the weaker residual albumin binding. The liver-disease work then tested the same binding logic in people whose DBP and albumin concentrations were reduced.

Sollid and colleagues added common DBP phenotype information inside a randomised supplementation cohort. The two GC loss-of-function reports provided a different kind of evidence again: rare genetic natural experiments in which functional circulating DBP was absent. These designs answer different questions, which is why the strongest interpretation comes from their convergence rather than from treating any one study as decisive for every clinical situation.

What does this evidence not tell us?

It does not establish a universal tissue-access rule for free, albumin-bound or DBP-bound 25(OH)D. It does not define a universal free 25(OH)D target. It also does not show that a person with ordinary low total 25(OH)D and normal carrier biology resembles someone with complete genetic absence of DBP.

The key distinction is therefore physiological rather than prescriptive: carrier proteins shape what a total concentration represents. How that should affect interpretation depends on the person’s binding environment, the measurement method and the question being asked.

What should the reader take from this?

The best-supported model is conditional rather than competitive. Total 25(OH)D is a useful measure of the whole circulating pool. Free 25(OH)D identifies the unbound component. Albumin-bound 25(OH)D sits between the dominant DBP-bound reservoir and the free pool in binding strength. Changes in carrier biology can alter the relationship among them.

That physiological distinction becomes especially important when interpreting laboratory measurements. Continue to Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D for the distinction between the two major metabolites used in testing, or to Free Versus Total Vitamin D Measurement and Interpretation: Full Study for the direct free-versus-total question.

Primary studies

Bikle DD et al., 1986. Assessment of the Free Fraction of 25-Hydroxyvitamin D in Serum and Its Regulation by Albumin and the Vitamin D-Binding Protein.

Bikle DD et al., 1986. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.

Sollid ST et al., 2016. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.

Henderson CM et al., 2019. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.

Banerjee RR et al., 2021. Very Low Vitamin D in a Patient With a Novel Pathogenic Variant in the GC Gene That Encodes Vitamin D-Binding Protein.

Related reading

Original sources